I used the Word Zombie in referencing Wallstreet leading this
Company, into the bazzaro World of over paying for M&A's that
Private equity has managed.
Including Duane Reade and Alliance Boots/KKR, at least KKR is sticking around with Stefano Pessina, who actually has a plan.
The risk they face is lower Rx reimburments payments both abroad and in the US..
The second problem is provider payments lagging as interest expense increases on debt, with the execption of China.
AS the Wickedone stated Walgreens has used its biggest gun for its balance sheet enhancement on A/B and now the only fire power left is in A/B control.
A interesting note is the new serverance agreements signed by the line in the Sand Group...
KKR Took a underwritting position in the Bond offering along with some other large funds, is it any wonder the stock price after the release is not falling...
Exposure and liquidity with a bond rating downgrade are traders bread and butter, Volitility looks to be baked into the deal with the current management and you know Wallstreet hates uncertainty.
GLTA!!!
News 
Market Data 
Discover 
